Juvenile localized scleroderma: Clinical and epidemiological features in 750 children. An international study

Rheumatology

Volumn 45, Issue 5, 2006, Pages 614-620

  Zulian, F ^a,u   Athreya, B H ^b   Laxer, R ^c   Nelson, A M ^d   Feitosa de Oliveira, S K ^e   Punaro, M G ^a   Cuttica, R ^f   Higgins, G C ^g   Van Suijlekom Smit, L W A ^h   Moore, T L ⁱ   Lindsley, C ^j   Garcia Consuegra, J ^k   Esteves Hilario M O ^l   Lepore, L ^m   Silva, C A ⁿ   Machado, C ^o   Garay, S M ^p   Uziel, Y ^q   Martini, G ^a   Foeldvari, I ^r   Peserico, A ^s   Woo, P ^t   Harper, J ^t   more..

^a Department of Pediatrics ^*  (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d MAYO CLINIC   (United States)

^e Instituto de Puericultura e Pediatria Martagao Gesteira   (Brazil)

^f HOSPITAL GENERAL DE NIÑOS PEDRO DE ELIZALDE   (Argentina)

^g NATIONWIDE CHILDREN S HOSPITAL   (United States)

^h SOPHIA CHILDREN S HOSPITAL   (Netherlands)

ⁱ Cardinal Glennon Hospital   (United States)

^j UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^k HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^l FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^m INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

ⁿ UNIVERSITY OF SÃO PAULO   (Brazil)

^o SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^p Hospital de Ninos Sor Maria Ludovica   (Argentina)

^q MEIR MEDICAL CENTER   (Israel)

^r Klinikum Eilbek   (Germany)

^s Dermatology Clinic   (Italy)

^t GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^u UNIVERSITY OF PADOVA   (Italy)

more..

Author keywords

Morphea; Parry Romberg syndrome; Progressive hemifacial atrophy; Scleroderma; Scleroderma en coup de sabre

Indexed keywords

AGENTS ACTING ON THE EYE; ANTICONVULSIVE AGENT; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CARDIOLIPIN ANTIBODY; CENTROMERE ANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; EMOLLIENT AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHOXSALEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PROKINETIC AGENT; RHEUMATOID FACTOR; SCL 70 ANTIBODY; STEROID; VITAMIN D;

ADOLESCENT; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CLINICAL FEATURE; DEMOGRAPHY; DISEASE CLASSIFICATION; DISEASE DURATION; DRUG USE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; INFANT; LABORATORY TEST; LINEAR SCLERODERMA; LOCALIZED SCLERODERMA; MAJOR CLINICAL STUDY; MALE; MORPHEA; PATIENT CARE; PRIORITY JOURNAL; PUVA; RHEUMATIC DISEASE;

ADOLESCENT; AGE OF ONSET; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHILD; CHILD, PRESCHOOL; ENVIRONMENT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFANT, NEWBORN; INTERNATIONAL COOPERATION; MALE; METHOTREXATE; RHEUMATIC DISEASES; RISK FACTORS; SCLERODERMA, LOCALIZED;

EID: 33646204698     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei251     Document Type: Article

References (38)

1. Peterson LS, Nelson AM, Su WPD. Classification of morphea (localized scleroderma). Mayo Clin Proc 1995;70:1068-76.
2. Murray KJ, Laxer RM. Scleroderma in children and adolescents. Rheum Dis Clin North Am 2002;28:603-24.
3. Uziel Y, Krafchik BR, Silverman ED, Thorner PS, Laxer RM. Localized scleroderma in childhood: A report of 30 cases. Semin Arthritis Rheum 1994;23:328-40.
4. Vancheeswaran R, Black CM, David J et al. Childhood onset scleroderma: is it different from adult onset disease. Arthritis Rheum 1996;39:1041-49.
5. Zulian F. Systemic manifestations in localized scleroderma. Curr Rheumatol Rep 2004;6:417-24.
6. Miller MT, Sloane H, Goldberg MF, Grisoland J, Frenke M, Mafee M. Progressive hemifacial atrophy. J Pediatr Ophthalmol Strabismus 1987;24:27-36.
7. Marzano AV, Menni S, Parodi A et al. Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases. Eur J Dermatol 2003;13:171-6.
8. Bodemer C, Belon M, Hamel-Teillac D et al. Scleroderma in children: A retrospective study of 70 cases. Ann Dermatol Venereol 1999; 126:691-4.
9. Christianson HB, Dorsey CS, Kierland RR, O'Leary PA. Localized scleroderma: A clinical study of two-hundred and thirty-five cases. Arch Dermatol 1956;74:629-39.
10. Blaszczyk M, Krysicka C, Jablonska S. Childhood scleroderma and its peculiarities. Cutis 1996;58:141-52.
11. Jablonska S, Blaszczyk M, Rosinska D. Progressive facial hemiatrophy and scleroderma en coup de sabre. Clinical presentation and course as related to the onset in early childhood and young adults. Arch Argent Dermatol 1998;48:125-8.
12. Blaszczyk M, Krolicki L, Krasu M, Glinska O, Jablonska S. Progressive facial hemiatrophy: Central nervous system involvement and relationship with scleroderma en coup de sabre. J Rheumatol 2003;30:1997-2004.
13. Segal P, Jablonska S, Mrzyglod S. Ocular changes in linear scleroderma Am J Ophthalmol 1961;51:807-13.
14. Muchnick RS, Sherrell JA, Rees DT. Ocular manifestations and treatment of hemifacial atrophy. Am J Ophthalmol 1979;88:889-97.
15. Rosenberg AM, Uziel Y, Krafchik BR et al. Antinuclear antibodies in children with localized scleroderma. J Rheumatol 1994;22:2337-43.
16. Takehara K, Moroi Y, Nakabayashi Y, Ishibashi Y. Antinuclear antibodies in localized scleroderma. Arthritis Rheum 1983;26:612-6.
17. Garcia-De La Torre I, Castello-Sendra J, Esgleyes-Ribot T, Martinez-Bonilla G, Guerrerosantos J, Fitzler MJ. Autoantibodies in Parry-Romberg syndrome: A serologic study of 14 patients. J Rheumatol 1995;22:73-77.
18. Orozco-Covarrubias L, Guzman-Meza A, Ridaura-Sanz C, Carrasco Daza D, Sosa-de-Martinez C, Ruiz-Maldonado R. Scleroderma 'en coup de sabre' and progressive facial hemiatrophy. Is it possible to differentiate them? J Eur Acad Dermatol Venereol 2002;16:361-6.
19. Pensler JM, Murphy GF, Mulliken JB. Clinical and ultrastructural studies of Romberg's hemifacial atrophy. Plast Reconstr Surg 1990;85:669-74.
20. Blaszczyk M, Jablonska S. Linear scleroderma en coup de sabre. Relationship with progressive facial hemiatrophy (PFH). Adv Exp Med Biol 1999;455:101-4.
21. Winkelmann RK. Localized cutaneous scleroderma. Semin Dermatol 1985;4:90-103.
22. Wadud MA, Bose BK, Al Nasir T. Familial localized scleroderma from Bangladesh: Two case reports. Bangladesh Med Res Counc Bull 1989;15:15-9.
23. Kass H, Hanson V, Patrick J, Centeno LM, Moore ME. Scleroderma in childhood. J Pediatr 1966;68:243-56.
24. Ree RB, Bennett J. Localized scleroderma in father and daughter. Arch Dermatol 1953;68:360-1.
25. De Keyser F, Peene I, Joos R, Naeyaert JM, Messiaen L, Veys EM. Occurrence of scleroderma in monozygotic twins. J Rheumatol 2000;27:2267-9.
26. Shelkovitz-Shiloh I, Ehrenfeld M, Schewch-Millet M, Feinstein A. Coexistence of family systemic lupus erythematosus and localized scleroderma. Int J Dermatol 1992;31:819-20.
27. Mackel SE, Kozin F, Ryan LM, Sheth KJ, Jordon RE. Concurrent linear scleroderma and systemic lupus erythematosus: A report of two cases. J Invest Dermatol 1979;73:368-72.
28. Mork NJ. Clinical and histopathologic morphea with immunological evidence of lupus erythematosus: A case report. Acta Derm Venereol 1981;61:367-8.
29. Becker KG, Simon RM, Bailey-Wilson JE et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA 1998;95:9979-84.
30. Falanga V, Medsger TA, Reichlin M, Rodnan GP. Linear scleroderma: clinical spectrum, prognosis and laboratory abnormalities. Ann Intern Med 1986;104:849-57.
31. Blaszczyk M, Jarzabek-Chorleska M, Jablonska S. Relationship between cutaneous and systemic scleroderma. Are immunopathological studies helpful in evaluating transition of cutaneous to systemic scleroderma? Przegl Dermatol 2000;2:119-25.
32. Rondinone R, Germino M, Sartori E et al. Autoimmune disorders in localized scleroderma. Arch Dermatol Res 1990;282:477-9.
33. Ruffatti A, Peserico A, Glorioso S et al. Anticentromere antibody in localized scleroderma. J Am Acad Dermatol 1986;15:637-42.
34. Jablonska S, Chorzelski TP, Blaszczyk M. Clinical relevance of immunologic findings in scleroderma. Clin Dermatol 1993;10:407-21.
35. Seyger MM, van den Hoogen FH, de Boo T, de Jong EM. Low-dose methotrexate in the treatment of widespread morphea. J Am Acad Dermatol 1998;39:220-5.
36. Uziel Y, Feldman BM, Krafchik BR, Yeung RS, Laxer RM. Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr 2000;136:91-5.
37. Walsh J, Martini G, Murray KJ, Woo P, Black CM. Evaluation and treatment of childhood onset localized scleroderma. Arthritis Rheum 1999;42:S231.
38. Falanga V, Medsger TA Jr. D-penicillamine in the treatment of localised scleroderma. Arch Dermatol 1990;126:609-12.